US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Zuleika Gold Limited (ZAG) 銘柄情報

Zuleika Gold Limited (ZAG)

0.034

-0.002

(-5.56%)

終了 7月4日 3:00PM

Zuleika Gold Limited (ZAG) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.034

( -5.56% )

買値

0.035

売値

0.04

出来高

147,818

0.034 日の範囲 0.035

0.014 52 週間の範囲 0.056

時価総額

前日終値

0.036

始値

0.035

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 387,912

発行済株式数

926,879,927

配当利回り

PER

0.66

1 株当たり利益 (EPS)

0.05

歳入

71.22k

純利益

38.79M

Zuleika Gold Limited engages in the exploration, acquisition, development, and evaluation of gold properties in Australia. Its flagship project is the 100% owned Zuleika gold project that covers an area of approximately 230 square kilometers located on the Zuleika Shear in the Kalgoorlie-Menzies gol... Zuleika Gold Limited engages in the exploration, acquisition, development, and evaluation of gold properties in Australia. Its flagship project is the 100% owned Zuleika gold project that covers an area of approximately 230 square kilometers located on the Zuleika Shear in the Kalgoorlie-Menzies goldfields. The company was formerly known as Dampier Gold Limited and changed its name to Zuleika Gold Limited in February 2021. Zuleika Gold Limited was incorporated in 2010 and is based in West Perth, Australia. 詳細を表示

セクター

Materials

業界

Mining

ウェブサイト

zuleikagold.com.au

本社

West Perth, Australia

設立

2026

Zuleika Gold Limited is listed in the Materials sector of the オーストラリア証券取引所 with ticker ZAG. The last closing price for Zuleika Gold was AUD0.04. Over the last year, Zuleika Gold shares have traded in a share price range of AUD 0.014 to AUD 0.056.

Zuleika Gold currently has 926,879,927 shares in issue. The market capitalisation of Zuleika Gold is AUD31.51 million. Zuleika Gold has a price to earnings ratio (PE ratio) of 0.66.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.004	13.3333333333	0.03	0.043	0.03	2365617	0.03661311	DE
4	0.002	6.25	0.032	0.043	0.03	824908	0.03601121	DE
12	-0.002	-5.55555555556	0.036	0.043	0.029	522512	0.03441804	DE
26	-0.012	-26.0869565217	0.046	0.056	0.029	504351	0.0402234	DE
52	0.019	126.666666667	0.015	0.056	0.014	649672	0.03608939	DE
156	0.019	126.666666667	0.015	0.056	0.009	511996	0.02629235	DE
260	0.004	13.3333333333	0.03	0.056	0.009	525815	0.02762829	DE

ZAG - Frequently Asked Questions (FAQ)

What is the current Zuleika Gold Limited share price?

The current share price of Zuleika Gold Limited is AUD 0.034

How many Zuleika Gold Limited shares are in issue?

Zuleika Gold Limited has 926,879,927 shares in issue

What is the market cap of Zuleika Gold Limited?

The market capitalisation of Zuleika Gold Limited is AUD 31.51M

What is the 1 year trading range for Zuleika Gold Limited share price?

Zuleika Gold Limited has traded in the range of AUD 0.014 to AUD 0.056 during the past year

What is the PE ratio of Zuleika Gold Limited?

The price to earnings ratio of Zuleika Gold Limited is 0.66

What is the cash to sales ratio of Zuleika Gold Limited?

The cash to sales ratio of Zuleika Gold Limited is 429.49

What is the registered address of Zuleika Gold Limited?

The registered address for Zuleika Gold Limited is 8 Kings Park Road, West Perth, Western Australia, 6005

What is the Zuleika Gold Limited website address?

The website address for Zuleika Gold Limited is zuleikagold.com.au

Which industry sector does Zuleika Gold Limited operate in?

Zuleika Gold Limited operates in the Mining sector

williamssc

williamssc 3分前

Slide16 “Overall Conclusions: The survival benefit associated with DCVax-L treatment reflects a true treatment affect and was underestimated in the original analysis”

NASDAQ2020

NASDAQ2020 5分前

i will wait for Monday to grab some more ??

GoodGuyBill

GoodGuyBill 5分前

Brazen22, you’re trying to reduce three years of regulatory progress to one sentence: “You don’t have an approved MAA.”

Of course we don’t — yet. Approval is the destination. We have a validated MAA. What matters is whether NWBO has completed the steps that regulators require before a

NASDAQ2020

NASDAQ2020 6分前

THATS WHEN i ACCUMULATE. At The hammerbottom.

nowwhat2

nowwhat2 6分前

https://investorshub.advfn.com/uimage/uploads/2026/7/3/vwgethg_july_3_2y_plunge_sell.jpg

rizona

Slides! JAMA study UNDERESTIMATED survival benefit

https://nwbio.com/wp-content/uploads/NWBT-BNOS-slides-7-3-26MB-LP-final.pdf

rosemountbomber

rosemountbomber 8分前

I agree with your thinking and also what needs to be considered is after decimating the board, just a desire to be acquired doesn’t automatically make that happen. Some other party has to be interested in acquiring Amarin. What happens then if no one steps up?

chereb19

chereb19 9分前

This is another post built on false equivalence. Sharing Y-90 doesn't make two products the same any more than sharing aspirin makes every painkiller identical.

You keep calling them competitors while ignoring they're fundamentally different technologies. One is a hydrogel platform, t

NASDAQ2020

NASDAQ2020 10分前

Im glad I held my shares past $0.15

Idunno

Idunno 10分前

And don’t forget your buddy, AF. … .. .

Doc logic

Doc logic 11分前

HappyLibrarian,

You are mistakenly overstating my claim which is a common problem so no harm no foul. Manufacturing transition preparedness is what I am suggesting must be in place. Artisan will be utilized to start as NWBO has consistently stated and the MIA is based on that model.

rcaselli

rcaselli 11分前

Just knowing JCTB1 is here is good enuf for me, okay.
See ya all topside….
$LBRG

Idunno

Idunno 11分前

Have at it Brazen! ;) … .. . :)

CatfishHunter

CatfishHunter 13分前

Every biotech founder believes their design choice was the right one — that’s true of BetaGlue’s surgeon-founder and it was true of Fisher/Korenko too. Design rationale explains intent, not outcome. The question that matters is what the trial data shows for each product, not why either team picked t

asp42001

asp42001 14分前

Digital USIO & AI Payment Potential:

(USIO In-Part):

"Embedded payments are the hidden engine under the hood of the apps and platforms we use every day. When you buy a ticket through a sports app or pay for a round of golf lessons online, embedded payments are doing the

BigBadWolf

BigBadWolf 14分前

$Ownership😘 of @ this point w/ irrefutable DD
🤔https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177573771&txt2find=reactor

mgland

mgland 15分前

https://x.com/thommic/status/2072760144774005081

GTF

Just so you know the clock on the 12 month restricted period for SNTX divvy shares began on June 17th, 2026. It doesn't matter that the deliverance of shares to the gtvh shareholders is taking some time. The clock begins when SNTX creates and issues the shares...meaning the day OTCmarkets shows the

manibiotech

manibiotech 17分前

I like this line in couple of PSM analysis slides:

“ Conclusion: Based on these more precisely matched comparisons,
the survival benefit with DCVax-L was likely underestimated
in the original analysis”

Very encouraging . Now let’s see when MHRA does its jo

ErnieBilco

ErnieBilco 18分前

Good to know because I was thinking about letting it go but now I have a reason to hold

gdog

This is by far the Best piece Gary has written imho

https://garywallach.substack.com/p/from-qualification-to-harvest-could?r=3iu9hl&utm_campaign=post&utm_medium=web&triedRedirect=true

AngeloFoca

AngeloFoca 19分前

I doubt you will agree or bother reading what I have said but at least it wasn’t written by some AI.
I have read it all and you are right... I don't agree with ANY of it.

No, I don't believe they have done EVERYTHING right... But I do believe that had it been any other CEO...

rmoss

Stay away stay very far away........

flipper44

flipper44 21分前

I’m busy today, but these results are in line with what I expected. Excellent, and very helpful for all current and potential stakeholders. Great for patients! For current therapy as well as future improvements with combination therapy. Happy 4th Tomorrow! (Top notch for valuation)

stoxjock

stoxjock 22分前

Ok, This Explains it. I didn't know which Wall St (Or elsewhere in Europe like James St) Scoundrel "Creditors' were "Filing TWICE or even More' to get their Money from multiple Lehman Entities ..Frankly, those SCUM should be prosecuted for Fraud and Thrown in Jail for Good...

Zero Cpn Nts 20/06/27

Latitude Australia Credi...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。